| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/24/2012 | US8101406 Protective anti-glucan antibodies with preference for β-1,3-glucans |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101372 Diagnosis and therapy of cancer using SGP28-related molecules |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101187 Secreted Streptococcus pneumoniae proteins |
| 01/24/2012 | US8101185 Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation |
| 01/24/2012 | US8101183 Variable region sequences of IL-31 monoclonal antibodies |
| 01/24/2012 | US8101182 Methods and compositions for treating allergic diseases |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | US8101179 Anti-CD20 monoclonal antibody |
| 01/24/2012 | US8101178 Monoclonal antibody that specifically binds to tumor necrosis factor- alpha and comprises heavy chain complementarity determining region 1 (CDR1) for use in treating and preventing cell proliferative disorders; antitumor agents |
| 01/24/2012 | US8101177 Anti-VEGF antibodies |
| 01/24/2012 | US8101176 Compositions and methods related to TIM-3, a TH1-specific cell surface molecule |
| 01/24/2012 | US8101174 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 01/24/2012 | US8100169 Spray nozzle apparatus and method of use |
| 01/24/2012 | CA2508763C Human antibody producing mouse and method for producing human antibody using the same |
| 01/24/2012 | CA2501621C Immunization of non-human mammals against streptococcus equi |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2436754C Production of a monoclonal antibody by a transgenic avian |
| 01/24/2012 | CA2378802C Inactivated vaccine against feline calicivirus disease |
| 01/24/2012 | CA2344317C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/24/2012 | CA2260754C Novel vegf-like factor |
| 01/19/2012 | WO2012009705A1 Ang-2 binding complexes and uses thereof |
| 01/19/2012 | WO2012009631A1 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 01/19/2012 | WO2012009254A1 Stabilized formulations containing anti-ngf antibodies |
| 01/19/2012 | WO2012008595A1 Method for producing anti-lr11 antibody and standard for immunoassay |
| 01/19/2012 | WO2012008584A1 Method for creating antibodies, and antibodies |
| 01/19/2012 | WO2012008494A1 Uterine cancer test method, uterine cancer test drug, and antibody for uterine cancer antigen |
| 01/19/2012 | WO2012008397A1 Anti-epha2 antibody and use thereof |
| 01/19/2012 | WO2012008211A1 Rnf8-fha domain-modified protein and method of producing the same |
| 01/19/2012 | WO2012007951A1 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides |
| 01/19/2012 | WO2012007950A2 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides |
| 01/19/2012 | WO2012007896A1 Multifunctional antibody conjugates |
| 01/19/2012 | WO2012007849A2 Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| 01/19/2012 | WO2012007846A2 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 01/19/2012 | WO2012007688A1 Monoclonal antibodies to tetanus toxin |
| 01/19/2012 | WO2012007576A1 Superior efficacy of cd37 antibodies in cll blood samples |
| 01/19/2012 | WO2012007516A1 Use of antibodies against icam-1 in the treatment of patients with relapsed cancer |
| 01/19/2012 | WO2012007495A1 Antibodies specifically binding to human tslpr and methods of use |
| 01/19/2012 | WO2012007280A1 Novel antibody for the diagnosis and/or prognosis of cancer |
| 01/19/2012 | WO2012007167A1 Multispecific modular antibody |
| 01/19/2012 | WO2012006730A1 Diagnostic method for colitis |
| 01/19/2012 | WO2012006718A1 Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| 01/19/2012 | WO2011153243A3 Anti-angiogenesis therapy for treating gastric cancer |
| 01/19/2012 | WO2011152722A3 Cloning and exploitation of a functional r-gene from solanum x edinense |
| 01/19/2012 | WO2011149999A3 Method for preparing antibodies having improved properties |
| 01/19/2012 | WO2011123708A3 Genetic engineering of non-human animals for the production of chimeric antibodies |
| 01/19/2012 | WO2011112850A3 Humanized and chimeric anti-properdin antibodies |
| 01/19/2012 | WO2011112549A3 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/19/2012 | WO2011109285A3 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/19/2012 | WO2011103426A3 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof |
| 01/19/2012 | WO2011098762A3 Antibodies against cxcr4 |
| 01/19/2012 | WO2011091078A9 Antibody fc variants with enhanced complement activity |
| 01/19/2012 | WO2011034604A9 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 01/19/2012 | WO2010131733A9 Anti-axl antibody |
| 01/19/2012 | US20120017337 Genes regulating plant branching, promotors, genetic constructs containing same and uses thereof |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016109 Estrogen receptors and methods of use |
| 01/19/2012 | US20120016108 Compositions and methods for treating kidney disease |
| 01/19/2012 | US20120016107 Growth factor htter36 |
| 01/19/2012 | US20120016106 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8 associated disorders |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120016003 Pot1 alternative splicing variants |
| 01/19/2012 | US20120015890 Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases |
| 01/19/2012 | US20120015872 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015871 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015867 Therapeutic peptides and method |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015436 Degraded tpo agonist antibody |
| 01/19/2012 | US20120015424 Arginine Inactivation of Viruses |
| 01/19/2012 | US20120015402 Method of Proliferating Plasma Cells |
| 01/19/2012 | US20120015387 Marker peptides for determining the occurrence of an inflammatory state in a subject |
| 01/19/2012 | US20120015385 Doxorubicin immunoassay |
| 01/19/2012 | US20120015379 Diagnosis of bacillus anthracis infection based on detection of bacterial secreted biomarkers |
| 01/19/2012 | US20120015364 Method for the selection of endothelial cells death inducers via netrin-1 and its applications |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014977 NOVEL ALTERNATIVE SPLICING VARIANT OF OATP1B3 mRNA |
| 01/19/2012 | US20120014973 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
| 01/19/2012 | US20120014972 Influenza virus compositions and methods for universal vaccines |
| 01/19/2012 | US20120014969 ErbB3 ANTIBODIES |
| 01/19/2012 | US20120014967 Il-1beta binding antibodies and fragments thereof |
| 01/19/2012 | US20120014965 Compositions and methods of treating tumors |
| 01/19/2012 | US20120014964 Alpha synuclein toxicity |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |
| 01/19/2012 | US20120014960 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014957 Dual variable domain immunoglobulins and uses thereof |
| 01/19/2012 | US20120014954 Sparc binding scfvs |
| 01/19/2012 | US20120014952 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120014950 Antibodies That Specifically Bind to DR3 |
| 01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
| 01/19/2012 | US20120014945 Anti-Dengue Virus Antibodies |
| 01/19/2012 | US20120014941 Anti-bv8 antibodies and uses thereof |
| 01/19/2012 | US20120014940 Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies |
| 01/19/2012 | US20120014872 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |